About the Company
We do not have any company description for Q32 Bio Inc. at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $FIXX News
Q32 Bio Inc
Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in ...
Q32 Bio Announces Closing of Merger with Homology Medicines and Concurrent Private Placement of $42 Million
March 25, 2024 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis ...
Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer
WALTHAM, Mass., April 3, 2024 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, ...
Q32 Bio Inc. Common Stock (QTTB) Short Interest
Nasdaq provides information of company’s short interest and the average days it takes to cover them. Short interest and days to cover can be used to indicate market sentiment and gauge the stock ...
Q32 Bio Inc. Common Stock (QTTB) Historical NOCP
*Today’s High/Low is only updated during regular trading hours; and does not include trades occurring in pre-market or after-hours. Nasdaq Official Closing Price (NOCP)" is a process for ...
Q32 Bio Appoints Lee Kalowski as President & Chief Financial Officer
WALTHAM, Mass., April 3, 2024 /PRNewswire/ -- Q32 Bio Inc. (NASDAQ: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune ...
Q32 Bio Inc QTTB
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Q32 Bio Inc. (QTTB)
Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...
Q32 Bio Inc (QTTB)
On Wednesday, Oppenheimer began coverage of Q32 Bio Inc. (NASDAQ: QTTB), assigning the stock an Outperform rating and setting a price target of $50.00. The firm's optimism is ...
Loading the latest forecasts...